In the company’s news yesterday,
Kraig Biocraft Laboratories, Inc. announced that its scientific team is preparing to significantly increase the number of genetic insertions performed in the month of May. The team believes that the rate of DNA construct insertions in May will be twice the number that has been performed to date. Every targeted insertion has the potential to create a new recombinant fiber with commercial applications.
“We are now entering the next phase in which the team is reallocating recourses to genetic insertion,” stated CEO Kim Thompson. “This is directly related to our recent development of new DNA constructs that are specifically targeted for the production of new fusion silk proteins. We intend to dramatically ramp up the number of insertions performed in order to gain the maximum benefit from the new insertion packets.”
Kraig Biocraft aims to tap into the $92 billion market for high performance and technical fibers. Since Kraig Biocraft Laboratories signed an intellectual property and collaborative research agreement with the University of Notre Dame in 2007, the company has been a proud sponsor of scientific research and development within the university.
About QualityStocks
QualityStocks, based in Scottsdale, Arizona is a free service that collects data from hundreds Small-Cap and Micro-Cap online Investment Newsletters into one Free Daily Newsletter Report. QualityStocks is dedicated to assisting emerging public companies with their advertising efforts and now has over 750,000+ subscribers that receive The Daily Stock Newsletters.
Please see disclaimer on QualityStocks website: http://Disclaimer.QualityStocks.net
Forward-Looking Statement:
This release may contain forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. All forward-looking statements are inherently uncertain as they are based on current expectations and assumptions concerning future events or future performance of the company. Readers are cautioned not to place undue reliance on these forward-looking statements, which are only predictions and speak only as of the date hereof. Risks and uncertainties applicable to the company and its business could cause the company's actual results to differ materially from those indicated in any forward-looking statements.
